Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Schein to license proprietary chelating compound from SunPharm

Oct. 8, 1999

Carbamazepine for the prevention and treatment of alcohol withdrawal syndrome

Sep. 28, 1999

NIDA study sheds new insight on cocaine addiction process

Sep. 23, 1999

Nalmefene reduces relapse to heavy drinking

Sep. 22, 1999

MedImmune licenses catalytic antibody against cocaine

Sep. 17, 1999

Sublingual nicotine tablets as alternative to Nicorette gum: clinical results reported at FIP '99

Sep. 8, 1999

Ferriprox approved in Europe as second-line thalassemia therapy

Aug. 27, 1999

Advances in the immunotherapy of cocaine abuse at Scripps Research Institute

Aug. 26, 1999

Academic researchers identify MAb as effective treatment for PCP addiction

Aug. 25, 1999

New treatments for alcoholism reported by Lipha

Aug. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...